Biggest News Aggregation in the World
📰 Imux News

Page 3 - Imux News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Imux. Real-time updates on events, politics, business and more.

Contrasting (RAMP) & Its Rivals | Daily Political

Immunic, Inc. (NASDAQ:IMUX – Get Rating) has received a consensus recommendation of “Moderate Buy” from the six ratings firms that are covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the company. The […]
Immunic Inc Immunic Company Profile Dimensional Fund Advisors Metlife Investment Management Blackrock Inc Jpmorgan Chase Co

Immunic, Inc. (NASDAQ:IMUX) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Immunic, Inc. (NASDAQ:IMUX – Get Rating) has been assigned a consensus recommendation of “Moderate Buy” from the six brokerages that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and four have issued a buy recommendation on the company. The […]
Jpmorgan Chase Co Marshall Wace Immunic Company Profile Denali Advisors Immunic Inc Metlife Investment Management
Source: wkrb13.com

Immunic, Inc. (NASDAQ:IMUX) Receives $22.00 Consensus Price Target from Analysts

Shares of Immunic, Inc. (NASDAQ:IMUX – Get Rating) have been assigned an average rating of “Moderate Buy” from the six research firms that are currently covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, one has given a hold rating and four have issued a buy rating on […]
Immunic Inc Vanguard Group Inc Gratus Capital Blackrock Inc Artal Group Immunic Company Profile

Immunic, Inc. (NASDAQ:IMUX) CFO Buys $10,640.00 in Stock

Immunic, Inc. (NASDAQ:IMUX – Get Rating) CFO Glenn Whaley bought 3,500 shares of the company’s stock in a transaction dated Friday, June 3rd. The stock was acquired at an average price of $3.04 per share, for a total transaction of $10,640.00. Following the acquisition, the chief financial officer now directly owns 12,568 shares in the […]
Glenn Whaley Piper Sandler Immunic Company Profile Get Rating Securities Exchange Commission Zacks Investment Research Sphera Funds Management

Immunic, Inc. (NASDAQ:IMUX) CEO Daniel Vitt Acquires 5,000 Shares

Immunic, Inc. (NASDAQ:IMUX – Get Rating) CEO Daniel Vitt purchased 5,000 shares of Immunic stock in a transaction on Friday, June 3rd. The stock was bought at an average price of $3.10 per share, for a total transaction of $15,500.00. Following the completion of the acquisition, the chief executive officer now owns 368,877 shares in […]
Zurcher Kantonalbank Zurich Cantonalbank Piper Sandler Daniel Vitt Immunic Company Profile Get Rating Wells Fargo Company Zacks Investment Research

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Immunic, Inc. (NASDAQ:IMUX) Given Average Rating of "Hold" by Analysts

Shares of Immunic, Inc. (NASDAQ:IMUX – Get Rating) have been assigned a consensus rating of “Hold” from the six analysts that are covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a sell recommendation and three have given a buy recommendation to the company. The average 1-year price objective among brokerages that […]
Duane Nash Piper Sandler Northern Trust Corp Goldman Sachs Group Inc Zacks Investment Research Silverarc Capital Management

Brokerages Anticipate Immunic, Inc. (NASDAQ:IMUX) Will Post Earnings of -$0.76 Per Share

Wall Street brokerages expect Immunic, Inc. (NASDAQ:IMUX – Get Rating) to post earnings per share of ($0.76) for the current quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Immunic’s earnings, with estimates ranging from ($0.93) to ($0.58). Immunic posted earnings per share of ($0.82) in the same quarter last year, which […]
Zurcher Kantonalbank Zurich Cantonalbank Immunic Company Profile Get Rating Wells Fargo Company Zacks Investment Research Citigroup Inc Barclays Plc

Q2 2022 Earnings Estimate for Immunic, Inc. (NASDAQ:IMUX) Issued By Wedbush

Immunic, Inc. (NASDAQ:IMUX – Get Rating) – Wedbush raised their Q2 2022 earnings estimates for shares of Immunic in a report issued on Tuesday, May 10th. Wedbush analyst L. Moussatos now anticipates that the company will earn ($0.69) per share for the quarter, up from their prior forecast of ($0.77). Wedbush has a “Outperform” rating […]
Nova Scotia Morgan Stanley Immunic Company Profile Get Rating Zacks Investment Research Blackrock Inc Deutsche Bank

Analysts Set Immunic, Inc. (NASDAQ:IMUX) PT at $49.25

Shares of Immunic, Inc. (NASDAQ:IMUX – Get Rating) have been assigned an average rating of “Buy” from the six analysts that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and four have given a buy recommendation to the company. The […]
United States Zacks Investment Research Deutsche Bank Jpmorgan Chase Co American International Group Inc Citigroup Inc

StockNews.com Initiates Coverage on Immunic (NASDAQ:IMUX)

StockNews.com initiated coverage on shares of Immunic (NASDAQ:IMUX – Get Rating) in a research note issued to investors on Thursday. The brokerage set a “sell” rating on the stock. Other analysts have also recently issued research reports about the stock. Wedbush reiterated a “buy” rating and issued a $61.00 price objective on shares of Immunic […]
Zacks Investment Research Parkman Healthcare Partners Blackrock Inc Millennium Management Immunic Inc Get Rating

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science